REVATIO 20 mg, film-coated tablet 90 tablets
Active ingredients: Sildenafil, Sildenafil citrate
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet90 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- REVATIO 20 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- 10 plaquettes thermoformées prédécoupées (dose unitaire) PVC-Aluminium de 9 comprimés
- Marketing authorisation holder
- UPJOHN (PAYS-BAS)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 2 Jun 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68155950CIP73702406CIP133400937024068Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SILDÉNAFIL (CITRATE DE)comprimé | 28,090 mg · un comprimé | SA |
| SILDÉNAFILcomprimé | 20 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.